124 related articles for article (PubMed ID: 16847923)
1. Monoclonal antibody conjugated to gadolinium as a contrast agent for magnetic resonance imaging of human rectal carcinoma.
Kuriu Y; Otsuji E; Kin S; Nakase Y; Fukuda K; Okamoto K; Hagiwara A; Yamagishi H
J Surg Oncol; 2006 Aug; 94(2):144-8. PubMed ID: 16847923
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody A7 coupled to magnetic particles as a contrast enhancing agent for magnetic resonance imaging of human colorectal carcinoma.
Otsuji E; Kuriu Y; Okamoto K; Ichikawa D; Hagiwara A; Ito H; Nishimura T; Yamagishi H
Cancer Immunol Immunother; 2006 Jun; 55(6):728-33. PubMed ID: 16273351
[TBL] [Abstract][Full Text] [Related]
3. Local administration of monoclonal antibody-drug conjugate: a new strategy to reduce the local recurrence of colorectal cancer.
Kitamura K; Takahashi T; Kotani T; Miyagaki T; Yamaoka N; Tsurumi H; Noguchi A; Yamaguchi T
Cancer Res; 1992 Nov; 52(22):6323-8. PubMed ID: 1423277
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma.
Toma A; Otsuji E; Kuriu Y; Okamoto K; Ichikawa D; Hagiwara A; Ito H; Nishimura T; Yamagishi H
Br J Cancer; 2005 Jul; 93(1):131-6. PubMed ID: 15970924
[TBL] [Abstract][Full Text] [Related]
5. The demonstration of human tumors on nude mice using gadolinium-labelled monoclonal antibodies for magnetic resonance imaging.
Göhr-Rosenthal S; Schmitt-Willich H; Ebert W; Conrad J
Invest Radiol; 1993 Sep; 28(9):789-95. PubMed ID: 8225882
[TBL] [Abstract][Full Text] [Related]
6. Dynamic micro-magnetic resonance imaging of liver micrometastasis in mice with a novel liver macromolecular magnetic resonance contrast agent DAB-Am64-(1B4M-Gd)(64).
Kobayashi H; Saga T; Kawamoto S; Sato N; Hiraga A; Ishimori T; Konishi J; Togashi K; Brechbiel MW
Cancer Res; 2001 Jul; 61(13):4966-70. PubMed ID: 11431325
[TBL] [Abstract][Full Text] [Related]
7. Nanotemplate-engineered nanoparticles containing gadolinium for magnetic resonance imaging of tumors.
Zhu D; Lu X; Hardy PA; Leggas M; Jay M
Invest Radiol; 2008 Feb; 43(2):129-40. PubMed ID: 18197065
[TBL] [Abstract][Full Text] [Related]
8. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
9. Applicability of monoclonal antibody Fab fragments as a carrier of neocarzinostatin in targeting chemotherapy.
Otsuji E; Yamaguchi T; Tsuruta H; Yata Y; Nishi H; Okamoto K; Taniguchi K; Kato M; Kotani T; Kitamura K; Takahashi T
J Surg Oncol; 1996 Feb; 61(2):149-54. PubMed ID: 8606548
[TBL] [Abstract][Full Text] [Related]
10. [Clinical application of monoclonal antibody-drug conjugates in colorectal carcinoma].
Takahashi T; Sakita M; Yamaguchi T; Kitamura K; Hata K; Noguchi A
Gan To Kagaku Ryoho; 1988 May; 15(5):1702-9. PubMed ID: 2967049
[TBL] [Abstract][Full Text] [Related]
11. [Gadolinium-loaded nanoparticle as a novel molecular imaging contrast agent for magnetic resonance imaging].
Liu LZ; Guo GJ; Zeng MS; Lü YC; Liu XW; Cui CY; Wu PH; Li L
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):240-3. PubMed ID: 17425867
[TBL] [Abstract][Full Text] [Related]
12. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
[TBL] [Abstract][Full Text] [Related]
13. Intercellular imaging by a polyarginine derived cell penetrating peptide labeled magnetic resonance contrast agent, diethylenetriamine pentaacetic acid gadolinium.
Guo YM; Liu M; Yang JL; Guo XJ; Wang SC; Duan XY; Wang P
Chin Med J (Engl); 2007 Jan; 120(1):50-5. PubMed ID: 17254488
[TBL] [Abstract][Full Text] [Related]
14. Selective modification of NMR relaxation time in human colorectal carcinoma by using gadolinium-diethylenetriaminepentaacetic acid conjugated with monoclonal antibody 19-9.
Curtet C; Tellier C; Bohy J; Conti ML; Saccavini JC; Thedrez P; Douillard JY; Chatal JF; Koprowski H
Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4277-81. PubMed ID: 3459174
[TBL] [Abstract][Full Text] [Related]
15. Enhanced tumor MR imaging with gadolinium-loaded polychelating polymer-containing tumor-targeted liposomes.
Erdogan S; Medarova ZO; Roby A; Moore A; Torchilin VP
J Magn Reson Imaging; 2008 Mar; 27(3):574-80. PubMed ID: 18219628
[TBL] [Abstract][Full Text] [Related]
16. [Missile therapy using monoclonal antibody drug conjugates in colorectal carcinoma].
Takahashi T; Yamaguchi T; Yokota T; Kitamura K; Suzuyama H; Honda M; Otsuji E; Sawai K; Sakita M; Kotanagi H
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):931-7. PubMed ID: 2952068
[TBL] [Abstract][Full Text] [Related]
17. The effects of local hyperthermia on the catabolism of a radioiodinated chimeric monoclonal antibody.
Hauck ML; Zalutsky MR
Clin Cancer Res; 1998 Sep; 4(9):2071-7. PubMed ID: 9748121
[TBL] [Abstract][Full Text] [Related]
18. Cerebral blood volume quantification in a C6 tumor model using gadolinium per (3,6-anhydro) alpha-cyclodextrin as a new magnetic resonance imaging preclinical contrast agent.
Lahrech H; Perles-Barbacaru AT; Aous S; Le Bas JF; Debouzy JC; Gadelle A; Fries PH
J Cereb Blood Flow Metab; 2008 May; 28(5):1017-29. PubMed ID: 18183033
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of a new bioactivated paramagnetic gadolinium(III) complex [Gd(DOTA-FPG)(H2O)] for tracing gene expression.
Chang YT; Cheng CM; Su YZ; Lee WT; Hsu JS; Liu GC; Cheng TL; Wang YM
Bioconjug Chem; 2007; 18(6):1716-27. PubMed ID: 17935289
[TBL] [Abstract][Full Text] [Related]
20. Development of a conjugated gadolinium and cisplatin-gelatin possessing properties as an intravascular contrast agent for MR imaging.
Sonoda A; Nitta N; Ohta S; Seko A; Jo J; Morikawa S; Tabata Y; Takahashi M; Murata K
Eur J Radiol; 2009 Sep; 71(3):570-5. PubMed ID: 18502598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
